文献速递胃肠动力与功能性疾病

肠易激综合征中MRGPRX2阳性肥大细胞的表征

Characterisation of MRGPRX2+ mast cells in irritable bowel syndrome.
PubMed 文献 · Gut · 2025-06-06

该研究通过流式细胞术和活体成像表征健康人结肠各层MRGPRX2阳性肥大细胞,并比较肠易激综合征患者与健康志愿者的直肠活检。结果显示MRGPRX2激动剂可诱导健康结肠黏膜下肥大细胞脱颗粒和TRPV1敏化;肠易激综合征患者黏膜下肥大细胞对MRGPRX2激动剂的脱颗粒增强,直肠活检上清MRGPRX2激动活性升高且与P物质水平升高相关。结论认为MRGPRX2通路在肠易激综合征结肠中功能上调,支持其在腹痛中的作用。

要点

  • MRGPRX2阳性肥大细胞富集于健康人结肠黏膜下层和肌层。
  • 肠易激综合征患者黏膜下肥大细胞对MRGPRX2激动剂的脱颗粒增强。
  • 肠易激综合征直肠活检上清MRGPRX2激动活性升高,与P物质水平升高相关。

核心结论

  • MRGPRX2通路在肠易激综合征患者结肠中功能上调,支持其在肠易激综合征腹痛中的作用。

研究设计与样本

  • 使用流式细胞术表征健康人结肠各层肥大细胞及其他免疫细胞的MRGPRX2表达。
  • 使用活体成像评估MRGPRX2激动剂是否触发健康人结肠黏膜下 plexus 样本中肥大细胞脱颗粒及瞬时受体电位香草酸1(TRPV1)敏化。

主要发现

  • MRGPRX2阳性肥大细胞富集于健康人结肠黏膜下层和肌层。
  • MRGPRX2激动剂在健康结肠黏膜下层诱导肥大细胞脱颗粒和TRPV1敏化。
  • 肠易激综合征患者直肠MRGPRX2阳性肥大细胞频率未改变。
  • 肠易激综合征患者黏膜下肥大细胞对MRGPRX2激动剂的脱颗粒较健康志愿者增强。
  • 肠易激综合征患者直肠活检上清MRGPRX2激动活性较健康志愿者升高,且与P物质水平升高相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mast cell activation is an important driver of abdominal pain in irritable bowel syndrome (IBS). While evidence supports the role of IgE-mediated mast cell activation in visceral pain development in IBS, the role of pseudoallergic MRGPRX2-mediated mast cell activation in this process remains unknown. OBJECTIVE: We investigated whether MRGPRX2-mediated mast cell activation plays a role in abdominal pain development in patients with IBS. DESIGN: MRGPRX2 expression in mast cells and other immune cells was characterised across colon layers using flow cytometry. We evaluated whether MRGPRX2 agonists trigger mast cell degranulation and transient receptor potential vanilloid 1 (TRPV1) sensitisation in healthy human colonic submucosal plexus samples using live imaging. Rectal biopsies were then collected from patients with IBS and healthy volunteers (HV) and MRGPRX2+ mast cell frequency, MRGPRX2 expression per cell, mast cell degranulation kinetics in response to MRGPRX2 agonists, MRGPRX2 agonistic activity and presence of MRGPRX2 agonists in biopsy supernatants were assessed. RESULTS: MRGPRX2+ mast cells are enriched in the submucosa and muscularis of the healthy human colon. MRGPRX2 agonists induce mast cell degranulation and TRPV1 sensitisation in the healthy colon submucosa. While the frequency of rectal MRGPRX2+ mast cells was unaltered in IBS, submucosal mast cells showed increased degranulation in response to MRGPRX2 agonists in IBS compared with HV. MRGPRX2 agonistic activity was increased in IBS rectal biopsy supernatant compared with HV, which was associated with increased levels of substance P. CONCLUSION: The MRGPRX2 pathway is functionally upregulated in the colon of patients with IBS, supporting its role in abdominal pain in IBS.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Decraecker L, Cuende Estévez M, Van Remoortel S, et al. Characterisation of MRGPRX2+ mast cells in irritable bowel syndrome. Gut. 2025. PMID: 39988359. doi:10.1136/gutjnl-2024-334037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。